167 related articles for article (PubMed ID: 19178874)
21. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
22. Free and total carnitine concentrations in pig plasma after oral ingestion of various L-carnitine compounds.
Eder K; Felgner J; Becker K; Kluge H
Int J Vitam Nutr Res; 2005 Jan; 75(1):3-9. PubMed ID: 15830915
[TBL] [Abstract][Full Text] [Related]
23. Carnitines increase plasma levels of adenosine and ATP in humans.
Capecchi PL; Laghi Pasini F; Quartarolo E; Di Perri T
Vasc Med; 1997; 2(2):77-81. PubMed ID: 9546959
[TBL] [Abstract][Full Text] [Related]
24. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
26. Effect of l-carnitine chloride and its acetyl derivative on the electrophysiological derangement induced by palmityl-l-carnitine in isolated canine ventricular muscle.
Matsui K; Nakazawa M; Takeda K; Imai S
Jpn J Pharmacol; 1985 Oct; 39(2):263-70. PubMed ID: 4087570
[TBL] [Abstract][Full Text] [Related]
27. Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.
Ferrari R; Pasini E; Condorelli E; Boraso A; Lisciani R; Marzo A; Visiou O
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():17-23. PubMed ID: 2031870
[TBL] [Abstract][Full Text] [Related]
28. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model.
Mota SI; Pita I; Águas R; Tagorti S; Virmani A; Pereira FC; Rego AC
Arch Toxicol; 2021 Aug; 95(8):2769-2784. PubMed ID: 34164711
[TBL] [Abstract][Full Text] [Related]
30. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
31. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
32. Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes.
Cotter MA; Cameron NE; Keegan A; Dines KC
Metabolism; 1995 Sep; 44(9):1209-14. PubMed ID: 7666797
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
Kelly JG; Hunt S; Doyle GD; Laher MS; Carmody M; Marzo A; Arrigoni Martelli E
Eur J Clin Pharmacol; 1990; 38(3):309-12. PubMed ID: 2340852
[TBL] [Abstract][Full Text] [Related]
34. Effects of carnitine and its derivatives on gastric acid secretion in rats.
Valoti M; Benocci A; Marazova K; Mantovani P
Pharmacol Res; 1996; 34(5-6):219-24. PubMed ID: 9076846
[TBL] [Abstract][Full Text] [Related]
35. Carnitine derivatives: clinical usefulness.
Malaguarnera M
Curr Opin Gastroenterol; 2012 Mar; 28(2):166-76. PubMed ID: 22333562
[TBL] [Abstract][Full Text] [Related]
36. Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
Mikhailova TL; Sishkova E; Poniewierka E; Zhidkov KP; Bakulin IG; Kupcinskas L; Lesniakowski K; Grinevich VB; Malecka-Panas E; Ardizzone S; D'Arienzo A; Valpiani D; Koch M; Denapiene G; Vago G; Fociani P; Zerbi P; Ceracchi M; Camerini R; Gasbarrini G
Aliment Pharmacol Ther; 2011 Nov; 34(9):1088-97. PubMed ID: 21929562
[TBL] [Abstract][Full Text] [Related]
37. L-carnitine and carnitine ester transport in the rat small intestine.
Marciani P; Lindi C; Marzo A; Arrigoni Martelli E; Cardace G; Esposito G
Pharmacol Res; 1991 Feb; 23(2):157-62. PubMed ID: 2062791
[TBL] [Abstract][Full Text] [Related]
38. Effect of craniotomy on oxidative stress and its effect on plasma L-carnitine levels.
Li HT; Zhao ZH; Ding HY; Wang LX; Cao Y
Can J Physiol Pharmacol; 2014 Nov; 92(11):913-6. PubMed ID: 25310338
[TBL] [Abstract][Full Text] [Related]
39. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
Rebouche CJ
Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
[TBL] [Abstract][Full Text] [Related]
40. Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism.
Cipolla MJ; Nicoloff A; Rebello T; Amato A; Porter JM
J Vasc Surg; 1999 Jun; 29(6):1097-103. PubMed ID: 10359944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
